EC does not expect US FDA to reduce inspections during shutdown
The US Government shutdown is unlikely to reduce US Food and Drug Administration (FDA) inspection activity according to the European Commission.
Archives for September 30, 2013
Update
Cyprotex sets up at former UK AstraZeneca R&D site citing demand
Preclinical CRO Cyprotex has set up a laboratory at a former AstraZenca R&D facility that ceased drug development operations earlier this year.
MSD's API plant complements GSK acquisition, says Aspen
Aspen has acquired a Dutch API plant from MSD and a French sterile production site from GSK.
Another Indian manufacturer hit with warning letter for cGMP violations
Indian drug manufacturer Aarti Drug Limited was hit with a warning letter from the US FDA this summer after the agency found multiple cGMP violations.
US Gov shutdown causes furloughs for about half of FDA employees
The US government is set to shut down at least temporarily and the US FDA will see about half of its staff furloughed.
Kemwell inks first deal at new Indian biomanufacturing plant
Kemwell says it hopes to attract more Western customers following the first development and manufacture contract from its new Indian facility.